Acasti Pharma (ACST) just unveiled an announcement.
Acasti Pharma Inc. has signed an employment agreement with Prashant Kohli as its CEO, offering a $500,000 annual salary and up to a 50% performance-based bonus. The contract includes potential stock options under the company’s plan, subject to board approval and terms. Kohli’s role comes with confidentiality and non-compete clauses and, if terminated without cause, he is entitled to a year’s salary. The agreement ensures participation in standard company benefits and contains provisions for proprietary property rights and confidentiality.
For an in-depth examination of ACST stock, go to TipRanks’ Stock Analysis page.
